Medical Science Liaison

Medical Science Liaison

Servier is a global pharmaceutical group governed by a nonprofit foundation, committed to making a meaningful social impact for patients and contributing to a sustainable world. The Group’s unique governance model ensures its independence while fostering long‑term innovation, with 100 % of its profits reinvested in the company’s development. As a world leader in cardiometabolism and venous diseases, Servier drives transformative innovation in chronic conditions through a holistic approach, making patient adherence a priority across the globe.

Its ambition is to become a leading player in rare cancers, which is why the Group invests heavily in oncology, allocating close to 70 % of its R&D budget to this field. By leveraging precision medicine, Servier develops therapies that are targeted and effective. Bolstered by its success in oncology, Servier has expanded into neurology, a key driver of future growth.

The Group focuses on a select number of neuro‑degenerative diseases, where accurate patient profiling enables targeted therapeutic responses through precision medicine. To further enhance access to high‑quality, affordable care, Servier also provides an extensive range of generic medicines. In all its activities and at every stage of the medicine life cycle, the Group integrates the patient’s voice. Headquartered in France, Servier operates in close to 140 countries.

In 2023‑2024 the Group employed over 22,000 people worldwide and achieved sales revenue of €5.9 billion.

• To deliver field‑based medical information services.
• To respond to medical‑information requests in line with the ABPI Code of Practice and internal SOP.
• To maintain adequate audit‑trailed records of enquiry requests and responses.
• To identify frequently asked medical enquiry questions, prepare appropriate presentations and obtain the appropriate internal approval before the delivery of this response to a healthcare professional.
• To effectively collaborate and support all colleagues of the medical‑information team to ensure fair, balanced and accurate responses are provided to enquiries within a timely manner.

• To be involved in the setup, delivery and ongoing management of UK‑led Phase IV and non‑interventional studies.
• To support the process for Investigator‑Initiated Study requests in line with the company SOP.
• To comply with international and UK SOP’s relating to clinical research.

• To recognise, record and report potential adverse reactions that arise out of a medical enquiry in line with agreed company procedures.

• The mapping and validation of KOLs in line with Servier UK Standard Operating Procedures.
• To support the legitimate exchange of scientific and medical information with health professionals, including TAE as prioritised, through the organisation of 1:1 visits. This may include advance notification of new products and introductory disease‑management meetings when working in new therapy areas as set out in Clause 3 of ABPI Code of Practice.
• Provides valuable scientific insights to the medical affairs department, that can subsequently be shared with internal CFTs in line with the ABPI Code of Practice.
• Support the set‑up and delivery of regional advisory boards as indicated by Medical Affairs strategy when requested.

• To maintain a high level of scientific, clinical and environmental knowledge through courses, self‑initiated learning and attendance at appropriate meetings/congresses.
• To maintain a high level of understanding of the healthcare environment within key accounts from where requests are originating.
• To maintain personal awareness and up‑to‑date knowledge of implications for the Company of laws and regulations relating to medical information services in the pharmaceutical industry.
• In all matters and at all times, to work to the highest scientific and ethical standards.

• To liaise with relevant managers to identify and implement a strategy for the training of…